Universal anti-influenza vaccines based on viral HA2 and M2e antigens

Acta Virol. 2020;64(4):417-426. doi: 10.4149/av_2020_408.ABSTRACTAquatic birds are the main reservoir of influenza A viruses (IAVs). These viruses can infect humans repeatedly and cause acute respiratory disease with potential of spread in the form of epidemics. In addition, avian influenza viruses that overcome the interspecies barrier and adapt to humans can cause a world-wide pandemic with severe consequences to human health. Therefore, scientists are focused on the development of a "universal" vaccine with a broad protective efficacy, i.e. against different subtypes of influenza A viruses and not only against the currently co-circulating human epidemic strains. Nowadays, several new vaccine design strategies have been described. Most of them utilize the conserved stem part of influenza surface glycoprotein hemagglutinin (HA) or the ectodomain of M2 (M2e) protein with proton-channel activity. A comparison of the efficacy of novel vaccines and their protective mechanisms against influenza infection is discussed in this review and should be considered for the construction of the most effective broadly protective vaccine with minimal side effects. This is the essential goal in influenza virus research today, especially when the infection with new human coronavirus SARS-CoV-2 can interfere with the course of influenza virus infection. Keywords: influenza A virus; HA2 gp; M2 ectodomain; universal vaccine.PMID:33151738 | DOI:10.4149/av_2020_408
Source: Acta Virologica - Category: Infectious Diseases Authors: Source Type: research

Related Links:

áková The number of obese adults and children is increasing worldwide, with obesity now being a global epidemic. Around 2.8 million people die annually from clinical overweight or obesity. Obesity is associated with numerous comorbid conditions including hypertension, cardiovascular disease, type 2 diabetes, hypercholesterolemia, hypertriglyceridemia, nonalcoholic fatty liver disease, and cancer, and even the development of severe disease after infection with viruses. Over the past twenty years, a number of new viruses has emerged and entered the human population. Moreover, influenza (H1N1)pdm09 virus and...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
Last updated 1430 UK time 24th December 2021.  Items added that day flagged NEW.Research literature and scientific informationPubMedLess sensitive strategy (finds 100 items as of 21st December - found 28 on 13th)More sensitive strategy - same as strategy above but have added Omicron lineages, BA.1 and BA.2(finds 140 items as of 21st December  - found 67 on 13th.  Note: results include work on any aspect of COVID from UK postcodes BA1 and BA2).PubMed COVID-19 Clinical Query Select aspect (diagnosis, treatment, etc.) from the drop down boxPreprintsCOVID preprints from medRxiv and bioRxiv (sorted...
Source: Browsing - Category: Databases & Libraries Tags: coronavirus COVID-19 Source Type: blogs
             Basel, 24 November 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone with influenza (known as post-exposure prophylaxis). Xofluza is the first single-dose influenza medicine approved for post-exposure prophylaxis.“With today’s approval, Xofluza is now available as the first single-dos...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news
Acta Virol. 2020;64(4):417-426. doi: 10.4149/av_2020_408.ABSTRACTAquatic birds are the main reservoir of influenza A viruses (IAVs). These viruses can infect humans repeatedly and cause acute respiratory disease with potential of spread in the form of epidemics. In addition, avian influenza viruses that overcome the interspecies barrier and adapt to humans can cause a world-wide pandemic with severe consequences to human health. Therefore, scientists are focused on the development of a "universal" vaccine with a broad protective efficacy, i.e. against different subtypes of influenza A viruses and not only against...
Source: Acta Virologica - Category: Infectious Diseases Authors: Source Type: research
More News: Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Coronavirus | COVID-19 | Epidemics | Epidemiology | Flu Pandemic | Infectious Diseases | Influenza | Influenza Vaccine | Pandemics | Respiratory Medicine | SARS | Vaccines | Virology